Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$619M |
| 2 |
Citigroup
C
|
+$457M |
| 3 |
Cimpress
CMPR
|
+$379M |
| 4 |
Broadcom
AVGO
|
+$374M |
| 5 |
Apple
AAPL
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
RAI
Reynolds American Inc
RAI
|
+$348M |
| 2 |
Microsoft
MSFT
|
+$331M |
| 3 |
IQVIA
IQV
|
+$243M |
| 4 |
Costco
COST
|
+$193M |
| 5 |
St. Joe Company
JOE
|
+$168M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.21% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 13.77% |
| 4 | Industrials | 12.77% |
| 5 | Consumer Discretionary | 10.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1101
Keysight
KEYS
$54.5B
| $2.25M | ﹤0.01% |
53,915
+13,284
| +33% | +$544K |
|
1102
Coty
COTY
$2.33B
| $2.25M | ﹤0.01% |
135,831
+37,455
| +38% | +$678K |
|
1103
Teva Pharmaceuticals
TEVA
$35.9B
| $2.23M | ﹤0.01% |
127,036
-3,011,051
| -96% | -$67.7M |
|
1104
Textron
TXT
$16.6B
| $2.22M | ﹤0.01% |
41,264
+17,866
| +76% | +$888K |
|
|
TRIL
1105
DELISTED
Trillium Therapeutics Inc.
TRIL
| $2.21M | ﹤0.01% |
429,262
-115,031
| -21% | -$540K |
|
1106
Macy's
M
$6.15B
| $2.2M | ﹤0.01% |
100,658
+20,643
| +26% | +$454K |
|
1107
Advance Auto Parts
AAP
$3.37B
| $2.19M | ﹤0.01% |
22,093
-2,565
| -10% | -$259K |
|
1108
Eagle Materials
EXP
$6.6B
| $2.18M | ﹤0.01% |
20,441
-7,537
| -27% | -$719K |
|
1109
Gentex
GNTX
$4.88B
| $2.18M | ﹤0.01% |
110,107
-206,728
| -65% | -$3.76M |
|
|
LSXMA
1110
DELISTED
Liberty Media Corporation Series A Liberty SiriusXM Common Stock
LSXMA
| $2.17M | ﹤0.01% |
71,770
-291,776
| -80% | -$9.03M |
|
1111
Sprouts Farmers Market
SFM
$7.04B
| $2.17M | ﹤0.01% |
115,457
+97,506
| +543% | +$2.16M |
|
1112
Unilever
UL
$131B
| $2.15M | ﹤0.01% |
33,056
-19,172
| -37% | -$1.23M |
|
1113
Macerich
MAC
$7.32B
| $2.13M | ﹤0.01% |
38,750
+14,305
| +59% | +$802K |
|
1114
Olin
OLN
$2.64B
| $2.13M | ﹤0.01% |
+62,200
| New | +$1.94M |
|
|
VER
1115
DELISTED
VEREIT, Inc.
VER
| $2.09M | ﹤0.01% |
50,461
+16,318
| +48% | +$688K |
|
1116
HF Sinclair
DINO
$15.9B
| $2.08M | ﹤0.01% |
57,774
-581,181
| -91% | -$17.5M |
|
1117
Credit Acceptance
CACC
$6B
| $2.07M | ﹤0.01% |
+7,397
| New | +$1.94M |
|
1118
Healthcare Realty
HR
$7.42B
| $2.07M | ﹤0.01% |
69,152
-1,314,732
| -95% | -$39.9M |
|
1119
Arrow Electronics
ARW
$10.9B
| $2.05M | ﹤0.01% |
25,478
+6,218
| +32% | +$491K |
|
|
STAY
1120
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $2.02M | ﹤0.01% |
+101,200
| New | +$1.96M |
|
|
BDN
1121
Brandywine Realty Trust
BDN
$551M
| $2M | ﹤0.01% |
114,600
+82,000
| +252% | +$1.39M |
|
1122
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17B
| $1.94M | ﹤0.01% |
19,098
| – | – |
|
|
DISCK
1123
DELISTED
Discovery, Inc. Series C Common Stock
DISCK
| $1.93M | ﹤0.01% |
95,015
+34,092
| +56% | +$765K |
|
1124
Liberty Broadband Class A
LBRDA
$4.14B
| $1.92M | ﹤0.01% |
20,400
| – | – |
|
1125
iShares TIPS Bond ETF
TIP
$14.5B
| $1.92M | ﹤0.01% |
16,895
| – | – |
|
Similar funds
Janus Henderson Group's Q3 2017 Portfolio in Review
As of Q3 2017, Janus Henderson Group held 1,386 positions worth $156B, up 5.9% from $147B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Janus Henderson Group's Q3 2017 filing shows 78 new, 598 increased, 569 reduced and 102 closed positions. Its largest new stake was Medtronic: 7,457,362 shares worth $580M. The largest sale was Reynolds American Inc, an estimated $348M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2017 buy was Medtronic: 7,457,362 shares worth $580M.
- Janus Henderson Group added most to Citigroup in Q3 2017, an estimated $457M increase.
- Janus Henderson Group's biggest Q3 2017 reduction was Microsoft, cutting an estimated $331M.
- Janus Henderson Group fully exited Reynolds American Inc in Q3 2017, selling an estimated $348M.
- Janus Henderson Group's ten largest holdings make up 14% of its $156B portfolio in Q3 2017.
- Janus Henderson Group opened 78 new positions and closed 102 in Q3 2017.
- Janus Henderson Group's portfolio value rose 5.9% quarter-over-quarter to $156B.
Based on Janus Henderson Group's 13F filing for Q3 2017, filed 14 Nov 2017.